Loading clinical trials...
Loading clinical trials...
GDM is characterized by decreased insulin sensitivity, decreased insulin secretion, or a combination of both. Women with GDM are at significant risk for overt T2DM later in life, and postpartum insuli...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alabama at Birmingham
Collaborators
NCT06310356 · Gestational Diabetes
NCT06925815 · Healthy Pregnant Women, Obese Pregnant Women, and more
NCT07517406 · Gestational Diabetes Mellitus (GDM), Pregnancy Complications, and more
NCT06988306 · Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)
NCT06548828 · Gestational Diabetes Mellitus in Pregnancy, Glucose Intolerance During Pregnancy, and more
University of Alabama at Birmingham
Birmingham, Alabama
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions